175 related articles for article (PubMed ID: 23893808)
1. The relationship between serum YKL-40 levels and severity of asthma.
Duru S; Yüce G; Ulasli SS; Erdem M; Kizilgün M; Kara F; Ardıc S
Iran J Allergy Asthma Immunol; 2013 Jul; 12(3):247-53. PubMed ID: 23893808
[TBL] [Abstract][Full Text] [Related]
2. YKL-40 in Asthma and its correlation with different clinical parameters.
Saba M; Sharif MR; Akbari H; Nikoueinejad H; Ramazani Jolfaii M
Iran J Allergy Asthma Immunol; 2014 Aug; 13(4):271-7. PubMed ID: 24659163
[TBL] [Abstract][Full Text] [Related]
3. YKL-40 is correlated with FEV1 and the asthma control test (ACT) in asthmatic patients: influence of treatment.
Lai T; Chen M; Deng Z; L Y; Wu D; Li D; Wu B
BMC Pulm Med; 2015 Jan; 15():1. PubMed ID: 25578181
[TBL] [Abstract][Full Text] [Related]
4. YKL-40 protein is a marker of asthma.
Specjalski K; Jassem E
J Asthma; 2011 Oct; 48(8):767-72. PubMed ID: 21899483
[TBL] [Abstract][Full Text] [Related]
5. YKL-40 protein correlates with the phenotype of asthma.
Specjalski K; Chełmińska M; Jassem E
Lung; 2015 Apr; 193(2):189-94. PubMed ID: 25663327
[TBL] [Abstract][Full Text] [Related]
6. YKL-40 in asthmatic patients, and its correlations with exacerbation, eosinophils and immunoglobulin E.
Tang H; Fang Z; Sun Y; Li B; Shi Z; Chen J; Zhang T; Xiu Q
Eur Respir J; 2010 Apr; 35(4):757-60. PubMed ID: 20356987
[TBL] [Abstract][Full Text] [Related]
7. The chitinase-like protein YKL-40: a possible biomarker of inflammation and airway remodeling in severe pediatric asthma.
Konradsen JR; James A; Nordlund B; Reinius LE; Söderhäll C; Melén E; Wheelock AM; Lödrup Carlsen KC; Lidegran M; Verhoek M; Boot RG; Dahlén B; Dahlén SE; Hedlin G
J Allergy Clin Immunol; 2013 Aug; 132(2):328-35.e5. PubMed ID: 23628340
[TBL] [Abstract][Full Text] [Related]
8. Increased YKL-40 and Chitotriosidase in Asthma and Chronic Obstructive Pulmonary Disease.
James AJ; Reinius LE; Verhoek M; Gomes A; Kupczyk M; Hammar U; Ono J; Ohta S; Izuhara K; Bel E; Kere J; Söderhäll C; Dahlén B; Boot RG; Dahlén SE;
Am J Respir Crit Care Med; 2016 Jan; 193(2):131-42. PubMed ID: 26372680
[TBL] [Abstract][Full Text] [Related]
9. Association of serum YKL-40 with the presence and severity of obstructive sleep apnea syndrome.
Li W; Yu Z; Jiang C
Lab Med; 2014; 45(3):220-5. PubMed ID: 25051073
[TBL] [Abstract][Full Text] [Related]
10. Elevated circulating levels of the serum acute-phase protein YKL-40 (chitinase 3-like protein 1) are a marker of obesity and insulin resistance in prepubertal children.
Kyrgios I; Galli-Tsinopoulou A; Stylianou C; Papakonstantinou E; Arvanitidou M; Haidich AB
Metabolism; 2012 Apr; 61(4):562-8. PubMed ID: 22036069
[TBL] [Abstract][Full Text] [Related]
11. The chitinase-like protein YKL-40 is not a useful biomarker for severe persistent asthma in children.
Santos CB; Davidson J; Covar RA; Spahn JD
Ann Allergy Asthma Immunol; 2014 Sep; 113(3):263-6. PubMed ID: 24954373
[TBL] [Abstract][Full Text] [Related]
12. Serum YKL-40 concentrations are elevated and correlated with disease severity in patients with obstructive sleep apnea syndrome.
Wang X; Xing GH
Scand J Clin Lab Invest; 2014 Jan; 74(1):74-8. PubMed ID: 24405178
[TBL] [Abstract][Full Text] [Related]
13. YKL-40: may be use as a new inflammatory biomarker in obstructive sleep apnea syndrome?
Duru S; Yüce G; Fırat H; Şimşek B; Uçar F; Ardıç S; Kurt EB
Tuberk Toraks; 2015 Sep; 63(3):158-64. PubMed ID: 26523896
[TBL] [Abstract][Full Text] [Related]
14. A chitinase-like protein in the lung and circulation of patients with severe asthma.
Chupp GL; Lee CG; Jarjour N; Shim YM; Holm CT; He S; Dziura JD; Reed J; Coyle AJ; Kiener P; Cullen M; Grandsaigne M; Dombret MC; Aubier M; Pretolani M; Elias JA
N Engl J Med; 2007 Nov; 357(20):2016-27. PubMed ID: 18003958
[TBL] [Abstract][Full Text] [Related]
15. Levels of YKL-40 in pleural effusions and blood from patients with pulmonary or pleural disease.
Kim HR; Jun CD; Lee KS; Cho JH; Jeong ET; Yang SH; Lee YJ; Park DS
Cytokine; 2012 Jun; 58(3):336-43. PubMed ID: 22480951
[TBL] [Abstract][Full Text] [Related]
16. Serum YKL-40 in psoriasis with and without arthritis; correlation with disease activity and high-resolution power Doppler ultrasonographic joint findings.
Ahmed SF; Attia EA; Saad AA; Sharara M; Fawzy H; El Nahrery EM
J Eur Acad Dermatol Venereol; 2015 Apr; 29(4):682-8. PubMed ID: 25087779
[TBL] [Abstract][Full Text] [Related]
17. High serum YKL-40 level in patients with COPD is related to hypoxemia and disease severity.
Gumus A; Kayhan S; Cinarka H; Kirbas A; Bulmus N; Yavuz A; Sahin U; Ozkaya S
Tohoku J Exp Med; 2013 Feb; 229(2):163-70. PubMed ID: 23364142
[TBL] [Abstract][Full Text] [Related]
18. Ghrelin-leptin network influences serum chitinase 3-like protein 1 (YKL-40) levels in obese prepubertal children.
Kyrgios I; Galli-Tsinopoulou A; Stylianou C
Regul Pept; 2013 May; 183():69-73. PubMed ID: 23501042
[TBL] [Abstract][Full Text] [Related]
19. Sputum YKL-40 levels and pathophysiology of asthma and chronic obstructive pulmonary disease.
Otsuka K; Matsumoto H; Niimi A; Muro S; Ito I; Takeda T; Terada K; Yamaguchi M; Matsuoka H; Jinnai M; Oguma T; Nakaji H; Inoue H; Tajiri T; Iwata T; Chin K; Mishima M
Respiration; 2012; 83(6):507-19. PubMed ID: 21968467
[TBL] [Abstract][Full Text] [Related]
20. Serum YKL-40/chitinase 3-like protein 1 level is an independent predictor of atherosclerosis development in patients with obstructive sleep apnea syndrome.
Bakırcı EM; Ünver E; Değirmenci H; Kıvanç T; Günay M; Hamur H; Büyüklü M; Ceyhun G; Topal E; Çoban TA
Turk Kardiyol Dern Ars; 2015 Jun; 43(4):333-9. PubMed ID: 26142786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
